Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2000 | 09-1999 | 09-1998 | 09-1993 | 09-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | 0 | 1 | 4,172 | 24 |
| Receivables | 1 | 10 | 4 | 59 | 1 |
| Inventories | 12 | 10 | 20 | 209 | 18 |
| Other current assets | 0 | 0 | 5 | 65 | 87 |
| TOTAL | $16 | $20 | $30 | $4,505 | $130 |
| Non-Current Assets | |||||
| PPE Net | 49 | 50 | 40 | 140 | 121 |
| Other Non-Current Assets | 0 | 0 | 6 | 292 | 263 |
| TOTAL | $49 | $50 | $46 | $433 | $384 |
| Total Assets | $65 | $80 | $80 | $4,938 | $515 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 24 | 20 | 260 | 28 | 13 |
| Accounts payable and accrued liabilities | 161 | 150 | 1,130 | 428 | 41 |
| Accrued Expenses | 471 | 340 | 200 | 70 | 28 |
| Other current liabilities | N/A | 10 | 290 | 288 | 0 |
| TOTAL | $1,155 | $1,030 | $2,660 | $914 | $292 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39 | 40 | 40 | -28 | 113 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 377 | 0 |
| TOTAL | $39 | $40 | $40 | $349 | $113 |
| Total Liabilities | $1,194 | $1,070 | $2,710 | $1,263 | $406 |
| Shareholders' Equity | |||||
| Common Shares | 5 | 5 | 3 | 2 | 0 |
| Retained earnings | -9,181 | -9,040 | -9,460 | -2,412 | -926 |
| Other shareholders' equity | 0 | 5 | 7 | 0 | 1 |
| TOTAL | $-1,129 | $-990 | $-2,620 | $3,675 | $109 |
| Total Liabilities And Equity | $65 | $80 | $90 | $4,938 | $515 |